Global Sulfasalazine 麻豆原创 Research Report 2024

Publication ID:

PB505256113

Publication Date:

May 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Sulfasalazine is a sulfanilamide antibiotic.It is an oral sulfonamide drug that is not easy to be absorbed. The absorbed part is decomposed into 5-amino salicylic acid and sulfonamide pyridine under the action of intestinal microorganisms.5-aminosalicylic acid stays in the intestinal wall for a long time after complexing with the connective tissue of the intestinal wall, which plays an antibacterial and anti-inflammatory role and plays an immunosuppressive role, such as reducing escherichia coli and clostridium difficile, and inhibiting the synthesis of prostaglanin and other inflammatory mediators, leukotrienes.Therefore, it is believed that the main component of this product is 5-aminosalicylic acid.Sulfamopyridine produced by the decomposition of this product showed weak antibacterial effect on intestinal flora.
The global Sulfasalazine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sulfasalazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sulfasalazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sulfasalazine include Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine and Hubei Wudang, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sulfasalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulfasalazine.
Report Scope
The Sulfasalazine market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sulfasalazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sulfasalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical
Segment by Type
Enteric Sugar Coated Tablet
Film-Coated Tablet
Other
Segment by Application
Crohn's Disease
Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
Ankylosing Spondylitis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sulfasalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sulfasalazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Sulfasalazine 麻豆原创 Overview
1.1 Product Overview and Scope of Sulfasalazine
1.2 Sulfasalazine Segment by Type
1.2.1 Global Sulfasalazine 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Enteric Sugar Coated Tablet
1.2.3 Film-Coated Tablet
1.2.4 Other
1.3 Sulfasalazine Segment by Application
1.3.1 Global Sulfasalazine 麻豆原创 Value by Application: (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
1.3.4 Ankylosing Spondylitis
1.3.5 Other
1.4 Global Sulfasalazine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Sulfasalazine Revenue 2019-2030
1.4.2 Global Sulfasalazine Sales 2019-2030
1.4.3 Global Sulfasalazine 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sulfasalazine 麻豆原创 Competition by Manufacturers
2.1 Global Sulfasalazine Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Sulfasalazine Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Sulfasalazine Average Price by Manufacturers (2019-2024)
2.4 Global Sulfasalazine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sulfasalazine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sulfasalazine, Product Type & Application
2.7 Sulfasalazine 麻豆原创 Competitive Situation and Trends
2.7.1 Sulfasalazine 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sulfasalazine Players 麻豆原创 Share by Revenue
2.7.3 Global Sulfasalazine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sulfasalazine Retrospective 麻豆原创 Scenario by Region
3.1 Global Sulfasalazine 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sulfasalazine Global Sulfasalazine Sales by Region: 2019-2030
3.2.1 Global Sulfasalazine Sales by Region: 2019-2024
3.2.2 Global Sulfasalazine Sales by Region: 2025-2030
3.3 Global Sulfasalazine Global Sulfasalazine Revenue by Region: 2019-2030
3.3.1 Global Sulfasalazine Revenue by Region: 2019-2024
3.3.2 Global Sulfasalazine Revenue by Region: 2025-2030
3.4 North America Sulfasalazine 麻豆原创 Facts & Figures by Country
3.4.1 North America Sulfasalazine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sulfasalazine Sales by Country (2019-2030)
3.4.3 North America Sulfasalazine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sulfasalazine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Sulfasalazine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sulfasalazine Sales by Country (2019-2030)
3.5.3 Europe Sulfasalazine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sulfasalazine 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Sulfasalazine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sulfasalazine Sales by Country (2019-2030)
3.6.3 Asia Pacific Sulfasalazine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sulfasalazine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Sulfasalazine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sulfasalazine Sales by Country (2019-2030)
3.7.3 Latin America Sulfasalazine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sulfasalazine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Sulfasalazine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sulfasalazine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sulfasalazine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sulfasalazine Sales by Type (2019-2030)
4.1.1 Global Sulfasalazine Sales by Type (2019-2024)
4.1.2 Global Sulfasalazine Sales by Type (2025-2030)
4.1.3 Global Sulfasalazine Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Sulfasalazine Revenue by Type (2019-2030)
4.2.1 Global Sulfasalazine Revenue by Type (2019-2024)
4.2.2 Global Sulfasalazine Revenue by Type (2025-2030)
4.2.3 Global Sulfasalazine Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Sulfasalazine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sulfasalazine Sales by Application (2019-2030)
5.1.1 Global Sulfasalazine Sales by Application (2019-2024)
5.1.2 Global Sulfasalazine Sales by Application (2025-2030)
5.1.3 Global Sulfasalazine Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Sulfasalazine Revenue by Application (2019-2030)
5.2.1 Global Sulfasalazine Revenue by Application (2019-2024)
5.2.2 Global Sulfasalazine Revenue by Application (2025-2030)
5.2.3 Global Sulfasalazine Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Sulfasalazine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Crescent Pharma Limited
6.1.1 Crescent Pharma Limited Corporation Information
6.1.2 Crescent Pharma Limited Description and Business Overview
6.1.3 Crescent Pharma Limited Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Crescent Pharma Limited Sulfasalazine Product Portfolio
6.1.5 Crescent Pharma Limited Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Sulfasalazine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Saaz-DS
6.3.1 Saaz-DS Corporation Information
6.3.2 Saaz-DS Description and Business Overview
6.3.3 Saaz-DS Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Saaz-DS Sulfasalazine Product Portfolio
6.3.5 Saaz-DS Recent Developments/Updates
6.4 KRKA
6.4.1 KRKA Corporation Information
6.4.2 KRKA Description and Business Overview
6.4.3 KRKA Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KRKA Sulfasalazine Product Portfolio
6.4.5 KRKA Recent Developments/Updates
6.5 Vintage
6.5.1 Vintage Corporation Information
6.5.2 Vintage Description and Business Overview
6.5.3 Vintage Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vintage Sulfasalazine Product Portfolio
6.5.5 Vintage Recent Developments/Updates
6.6 Qualitest
6.6.1 Qualitest Corporation Information
6.6.2 Qualitest Description and Business Overview
6.6.3 Qualitest Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qualitest Sulfasalazine Product Portfolio
6.6.5 Qualitest Recent Developments/Updates
6.7 NPS Medicinewise
6.6.1 NPS Medicinewise Corporation Information
6.6.2 NPS Medicinewise Description and Business Overview
6.6.3 NPS Medicinewise Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NPS Medicinewise Sulfasalazine Product Portfolio
6.7.5 NPS Medicinewise Recent Developments/Updates
6.8 Kamp Medicine
6.8.1 Kamp Medicine Corporation Information
6.8.2 Kamp Medicine Description and Business Overview
6.8.3 Kamp Medicine Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kamp Medicine Sulfasalazine Product Portfolio
6.8.5 Kamp Medicine Recent Developments/Updates
6.9 Hubei Wudang
6.9.1 Hubei Wudang Corporation Information
6.9.2 Hubei Wudang Description and Business Overview
6.9.3 Hubei Wudang Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hubei Wudang Sulfasalazine Product Portfolio
6.9.5 Hubei Wudang Recent Developments/Updates
6.10 Hebei Yinengpu
6.10.1 Hebei Yinengpu Corporation Information
6.10.2 Hebei Yinengpu Description and Business Overview
6.10.3 Hebei Yinengpu Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hebei Yinengpu Sulfasalazine Product Portfolio
6.10.5 Hebei Yinengpu Recent Developments/Updates
6.11 Shanxi Wanshou
6.11.1 Shanxi Wanshou Corporation Information
6.11.2 Shanxi Wanshou Sulfasalazine Description and Business Overview
6.11.3 Shanxi Wanshou Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanxi Wanshou Sulfasalazine Product Portfolio
6.11.5 Shanxi Wanshou Recent Developments/Updates
6.12 Fujian Fukang
6.12.1 Fujian Fukang Corporation Information
6.12.2 Fujian Fukang Sulfasalazine Description and Business Overview
6.12.3 Fujian Fukang Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fujian Fukang Sulfasalazine Product Portfolio
6.12.5 Fujian Fukang Recent Developments/Updates
6.13 Guangzhou Huahai
6.13.1 Guangzhou Huahai Corporation Information
6.13.2 Guangzhou Huahai Sulfasalazine Description and Business Overview
6.13.3 Guangzhou Huahai Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Guangzhou Huahai Sulfasalazine Product Portfolio
6.13.5 Guangzhou Huahai Recent Developments/Updates
6.14 WATSON LABS
6.14.1 WATSON LABS Corporation Information
6.14.2 WATSON LABS Sulfasalazine Description and Business Overview
6.14.3 WATSON LABS Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 WATSON LABS Sulfasalazine Product Portfolio
6.14.5 WATSON LABS Recent Developments/Updates
6.15 Pharmacia & Upjohn
6.15.1 Pharmacia & Upjohn Corporation Information
6.15.2 Pharmacia & Upjohn Sulfasalazine Description and Business Overview
6.15.3 Pharmacia & Upjohn Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Pharmacia & Upjohn Sulfasalazine Product Portfolio
6.15.5 Pharmacia & Upjohn Recent Developments/Updates
6.16 Chongqing Dikang
6.16.1 Chongqing Dikang Corporation Information
6.16.2 Chongqing Dikang Sulfasalazine Description and Business Overview
6.16.3 Chongqing Dikang Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chongqing Dikang Sulfasalazine Product Portfolio
6.16.5 Chongqing Dikang Recent Developments/Updates
6.17 Shanghai Xinyi Tianping Pharmaceutical
6.17.1 Shanghai Xinyi Tianping Pharmaceutical Corporation Information
6.17.2 Shanghai Xinyi Tianping Pharmaceutical Sulfasalazine Description and Business Overview
6.17.3 Shanghai Xinyi Tianping Pharmaceutical Sulfasalazine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shanghai Xinyi Tianping Pharmaceutical Sulfasalazine Product Portfolio
6.17.5 Shanghai Xinyi Tianping Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sulfasalazine Industry Chain Analysis
7.2 Sulfasalazine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sulfasalazine Production Mode & Process
7.4 Sulfasalazine Sales and 麻豆原创ing
7.4.1 Sulfasalazine Sales Channels
7.4.2 Sulfasalazine Distributors
7.5 Sulfasalazine Customers
8 Sulfasalazine 麻豆原创 Dynamics
8.1 Sulfasalazine Industry Trends
8.2 Sulfasalazine 麻豆原创 Drivers
8.3 Sulfasalazine 麻豆原创 Challenges
8.4 Sulfasalazine 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.